B. D. Walker and X. G. Yu, Unravelling the mechanisms of durable control of HIV-1, Nat Rev Immunol, vol.13, pp.487-498, 2013.

M. R. Betts, M. C. Nason, S. M. West, D. Rosa, S. C. Migueles et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8R T cells, Blood, vol.107, pp.4781-4789, 2006.

A. Saez-cirion, C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia et al., HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proc Natl Acad Sci U S A, vol.104, pp.6776-6781, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00142658

S. A. Migueles, M. S. Sabbaghian, W. L. Shupert, M. P. Bettinotti, F. M. Marincola et al., HLA BM5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors, Proc Natl Acad Sci U S A, vol.97, pp.2709-2714, 2000.

J. R. Almeida, D. A. Price, L. Papagno, Z. A. Arkoub, D. Sauce et al., Superior control of HIV-1 replication by CD8R T cells is reflected by their avidity, polyfunctionality, and clonal turnover, J Exp Med, vol.204, pp.2473-2485, 2007.

M. F. Chevalier, B. Julg, A. Pyo, M. Flanders, S. Ranasinghe et al., HIV-1-specific interleukin-21R CD4R T cell responses contribute to durable viral control through the modulation of HIV-specific CD8R T cell function, J Virol, vol.85, pp.733-741, 2011.

D. Z. Soghoian, H. Jessen, M. Flanders, K. Sierra-davidson, S. Cutler et al., HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome, Sci Transl Med, vol.4, pp.123-125, 2012.

S. Ranasinghe, S. Cutler, I. Davis, R. Lu, D. Z. Soghoian et al., Association of HLA-DRB1-restricted CD4(R) T cell responses with HIV immune control, Nat Med, vol.19, pp.930-933, 2013.

C. Hamimi, A. David, P. Versmisse, L. Weiss, T. Bruel et al., Dendritic cells from HIV controllers have low susceptibility to HIV-1 infection in vitro but high capacity to capture HIV-1 particles, PLoS One, vol.11, p.160251, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01375755

E. Martin-gayo, M. J. Buzon, Z. Ouyang, T. Hickman, J. Cronin et al., Potent cell-intrinsic immune responses in dendritic cells facilitate HIV-1-specific T cell immunity in HIV-1 elite controllers, PLoS Pathog, vol.11, p.1004930, 2015.

M. Bonneville, R. L. O'brien, and W. K. Born, Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity, Nat Rev Immunol, vol.10, pp.467-478, 2010.

A. Poggi and M. R. Zocchi, gdT lymphocytes as a first line of immune defense: old and new ways of antigen recognition and implications for cancer immunotherapy, Front Immunol, vol.5, p.575, 2014.

S. Boullier, M. Cochet, F. Poccia, and M. L. Gougeon, CDR3-independent gamma delta V delta 1R T cell expansion in the peripheral blood of HIV-infected persons, J Immunol, vol.154, pp.1418-1431, 1995.

F. Poccia, S. Boullier, H. Lecoeur, M. Cochet, Y. Poquet et al., Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons, J Immunol, vol.157, pp.449-461, 1996.

H. Li and C. D. Pauza, HIV envelope-mediated, CCR5/(4(7-dependent killing of CD4-negative (( T cells which are lost during progression to AIDS, Blood, vol.118, pp.5824-5831, 2011.

N. Soriano-sarabia, N. M. Archin, R. Bateson, N. P. Dahl, A. M. Crooks et al., Peripheral Vg9Vd2 T cells are a novel reservoir of latent HIV infection, PLoS Pathog, vol.11, p.1005201, 2015.

C. D. Pauza, B. Poonia, H. Li, C. Cairo, and S. Chaudhry, gammadelta T cells in HIV disease: past, present, and future, Front Immunol, vol.5, p.687, 2014.

N. Bhatnagar, P. M. Girard, M. Lopez-gonzalez, C. Didier, L. Collias et al., Potential role of Vdelta2(R) gammadelta T cells in regulation of immune activation in primary HIV infection, Front Immunol, vol.8, p.1189, 2017.

V. Appay and D. Sauce, Immune activation and inflammation in HIV-1 infection: causes and consequences, J Pathol, vol.214, pp.231-241, 2008.

M. Massanella, R. Fromentin, and N. Chomont, Residual inflammation and viral reservoirs: alliance against an HIV cure, Curr Opin HIV AIDS, vol.11, pp.234-241, 2016.

M. M. Lederman, N. T. Funderburg, R. P. Sekaly, N. R. Klatt, and P. W. Hunt, Residual immune dysregulation syndrome in treated HIV infection, Adv Immunol, vol.119, pp.51-83, 2013.

P. W. Hunt, J. Brenchley, E. Sinclair, J. M. Mccune, M. Roland et al., Relationship between T cell activation and CD4R T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy, J Infect Dis, vol.197, pp.126-133, 2008.

S. Krishnan, E. M. Wilson, V. Sheikh, A. Rupert, D. Mendoza et al., Evidence for innate immune system activation in HIV type 1-infected elite controllers, J Infect Dis, vol.209, pp.931-939, 2014.

F. Pereyra, J. Lo, V. A. Triant, J. Wei, M. J. Buzon et al., Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers, AIDS, vol.26, pp.2409-2412, 2012.

P. Y. Hsue, P. W. Hunt, A. Schnell, S. C. Kalapus, R. Hoh et al., Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis, AIDS, vol.23, pp.1059-1067, 2009.

N. Noel, F. Boufassa, C. Lecuroux, A. Saez-cirion, C. Bourgeois et al., Elevated IP10 levels are associated with immune activation and low CD4(R) T-cell counts in HIV controller patients, AIDS, vol.28, pp.467-476, 2014.

J. F. Okulicz, F. Boufassa, D. Costagliola, A. Ganesan, and O. Lambotte, Cancers in elite controllers: appropriate follow-up is essential, AIDS, vol.30, pp.1852-1855, 2016.

M. Pernas, L. Tarancon-diez, E. Rodriguez-gallego, J. Gomez, J. G. Prado et al., Factors leading to the loss of natural elite control of HIV-1 infection, J Virol, vol.92, pp.1805-1822, 2018.

N. Noel, N. Lerolle, C. Lecuroux, C. Goujard, A. Venet et al., Immunologic and virologic progression in HIV controllers: the role of viral 'blips' and immune activation in the ANRS CO21 CODEX study, PLoS One, vol.10, p.131922, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01415218

M. M. Sajadi, R. Pulijala, R. R. Redfield, and R. Talwani, Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors, AIDS, vol.26, pp.1879-1884, 2012.

R. S. Patil, S. A. Bhat, A. A. Dar, and S. V. Chiplunkar, The Jekyll and Hyde story of IL17-producing gammadeltaT cells, Front Immunol, vol.6, p.37, 2015.

D. Fenoglio, A. Poggi, S. Catellani, F. Battaglia, A. Ferrera et al., Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans, Blood, vol.113, pp.6611-6618, 2009.

G. Petitjean, M. F. Chevalier, F. Tibaoui, C. Didier, M. E. Manea et al., Level of double negative T cells, which produce TGF-beta and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection, AIDS, vol.26, pp.139-148, 2012.

V. Avettand-fenoel, F. Boufassa, J. Galimand, L. Meyer, C. Rouzioux et al., HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is, J Clin Virol, vol.42, pp.399-404, 2008.

D. J. Riedel, M. M. Sajadi, C. L. Armstrong, J. S. Cummings, C. Cairo et al., Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells, AIDS, vol.23, pp.1955-1964, 2009.

E. V. Acosta-rodriguez, L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno et al., Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells, Nat Immunol, vol.8, pp.639-646, 2007.

M. A. Kleinschek, K. Boniface, S. Sadekova, J. Grein, E. E. Murphy et al., Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation, J Exp Med, vol.206, pp.525-534, 2009.

B. Autran, F. Triebel, C. Katlama, W. Rozenbaum, T. Hercend et al., T cell receptor gamma/deltaR lymphocyte subsets during HIV infection, Clin Exp Immunol, vol.75, pp.206-210, 1989.

D. Rosa, S. C. Mitra, D. K. Watanabe, N. Herzenberg, L. A. Herzenberg et al., Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages, J Leukoc Biol, vol.70, pp.518-526, 2001.

C. Khairallah, T. H. Chu, and B. S. Sheridan, Tissue adaptations of memory and tissue-resident gamma delta T cells, Front Immunol, vol.9, p.2636, 2018.

V. Pitard, D. Roumanes, X. Lafarge, L. Couzi, I. Garrigue et al., Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection, Blood, vol.112, pp.1317-1324, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00356753

L. Couzi, V. Pitard, J. F. Moreau, P. Merville, and J. Dechanet-merville, Direct and indirect effects of cytomegalovirus-induced gammadelta T cells after kidney transplantation, Front Immunol, vol.6, p.3, 2015.

G. S. Olson, S. W. Moore, J. M. Richter, J. J. Garber, B. A. Bowman et al., Increased frequency of systemic proinflammatory Vdelta1(R) gammadelta T cells in HIV elite controllers correlates with gut viral load, Sci Rep, vol.8, p.16471, 2018.

L. D. Harris, N. R. Klatt, C. Vinton, J. A. Briant, B. Tabb et al., Mechanisms underlying gammadelta T-cell subset perturbations in SIV-infected Asian rhesus macaques, Blood, vol.116, pp.4148-4157, 2010.

A. Bansal, S. Sterrett, N. Erdmann, A. O. Westfall, J. Dionne-odom et al., Normal T-cell activation in elite controllers with preserved CD4R T-cell counts, AIDS, vol.29, pp.2245-2254, 2015.

D. Favre, J. Mold, P. W. Hunt, B. Kanwar, P. Loke et al., Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease, Sci Transl Med, vol.2, pp.32-36, 2010.

J. Falivene, Y. Ghiglione, N. Laufer, M. E. Socias, M. P. Holgado et al., Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(R) T-cell responses and disease progression, Sci Rep, vol.5, p.11511, 2015.

Z. Li, Y. Jiao, Y. Hu, L. Cui, D. Chen et al., Distortion of memory Vdelta2 gammadelta T cells contributes to immune dysfunction in chronic HIV infection, Cell Mol Immunol, vol.12, pp.604-614, 2015.

P. J. Dunne, C. O. Maher, M. Freeley, K. Dunne, A. Petrasca et al., CD3epsilon expression defines functionally distinct subsets of Vdelta1 T cells in patients with human immunodeficiency virus infection, Front Immunol, vol.9, p.940, 2018.

S. Dandekar, M. D. George, and A. J. Baumler, Th17 cells, HIV and the gut mucosal barrier, Curr Opin HIV AIDS, vol.5, pp.173-178, 2010.

A. Leon, L. Leal, B. Torres, C. Lucero, A. Inciarte et al., Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients, AIDS, vol.29, pp.675-681, 2015.

J. Vesterbacka, J. Rivera, K. Noyan, M. Parera, U. Neogi et al., Peripheral blood CCR4R CCR6R and CXCR3RCCR6RCD4R T cells are highly permissive to HIV-1 infection, J Immunol, vol.7, pp.1604-1616, 2010.

H. Sun, D. Kim, X. Li, M. Kiselinova, Z. Ouyang et al., Th1/17 polarization of CD4 T cells supports HIV-1 persistence during antiretroviral therapy, J Virol, vol.89, pp.11284-11293, 2015.